Research ArticleArticle
The Effect of Different Remission Definitions on Identification of Predictors of Both Point and Sustained Remission in Rheumatoid Arthritis Treated with Anti-TNF Therapy
Cheryl Barnabe, Joanne Homik, Susan G. Barr, Liam Martin and Walter P. Maksymowych
The Journal of Rheumatology July 2014, jrheum.131451; DOI: https://doi.org/10.3899/jrheum.131451
Cheryl Barnabe
From the Department of Medicine, and the Department of Community Health Sciences, University of Calgary, Calgary; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada. The Alberta Biologics Pharmacosurveillance Program (ABioPharm) was supported by a grant from Alberta Health and Wellness for the study period reported. Data analyst costs were paid through the Department of Medicine and the Arthur J.E. Child Chair in Rheumatology, University of Calgary. C. Barnabe, MD, MSc, FRPC, Assistant Professor, Department of Medicine, and the Department of Community Health Sciences, University of Calgary; J. Homik, MD, MSc, FRCPC, Associate Professor, Department of Medicine, University of Alberta; S.G. Barr, MD, MSC, FRCPC, Associate Professor; L. Martin, MB, ChB, FRCPC, Professor, Department of Medicine, University of Calgary; W.P. Maksymowych, MB, ChB, FRCPC, Professor, Department of Medicine, University of Alberta. Address correspondence to Dr. C. Barnabe, 3330 Hospital Dr NW, Calgary, Alberta T2N 4N1, Canada. E-mail: ccbarnab@ucalgary.ca. Accepted for publication April 3, 2014.
Joanne Homik
From the Department of Medicine, and the Department of Community Health Sciences, University of Calgary, Calgary; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada. The Alberta Biologics Pharmacosurveillance Program (ABioPharm) was supported by a grant from Alberta Health and Wellness for the study period reported. Data analyst costs were paid through the Department of Medicine and the Arthur J.E. Child Chair in Rheumatology, University of Calgary. C. Barnabe, MD, MSc, FRPC, Assistant Professor, Department of Medicine, and the Department of Community Health Sciences, University of Calgary; J. Homik, MD, MSc, FRCPC, Associate Professor, Department of Medicine, University of Alberta; S.G. Barr, MD, MSC, FRCPC, Associate Professor; L. Martin, MB, ChB, FRCPC, Professor, Department of Medicine, University of Calgary; W.P. Maksymowych, MB, ChB, FRCPC, Professor, Department of Medicine, University of Alberta. Address correspondence to Dr. C. Barnabe, 3330 Hospital Dr NW, Calgary, Alberta T2N 4N1, Canada. E-mail: ccbarnab@ucalgary.ca. Accepted for publication April 3, 2014.
Susan G. Barr
From the Department of Medicine, and the Department of Community Health Sciences, University of Calgary, Calgary; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada. The Alberta Biologics Pharmacosurveillance Program (ABioPharm) was supported by a grant from Alberta Health and Wellness for the study period reported. Data analyst costs were paid through the Department of Medicine and the Arthur J.E. Child Chair in Rheumatology, University of Calgary. C. Barnabe, MD, MSc, FRPC, Assistant Professor, Department of Medicine, and the Department of Community Health Sciences, University of Calgary; J. Homik, MD, MSc, FRCPC, Associate Professor, Department of Medicine, University of Alberta; S.G. Barr, MD, MSC, FRCPC, Associate Professor; L. Martin, MB, ChB, FRCPC, Professor, Department of Medicine, University of Calgary; W.P. Maksymowych, MB, ChB, FRCPC, Professor, Department of Medicine, University of Alberta. Address correspondence to Dr. C. Barnabe, 3330 Hospital Dr NW, Calgary, Alberta T2N 4N1, Canada. E-mail: ccbarnab@ucalgary.ca. Accepted for publication April 3, 2014.
Liam Martin
From the Department of Medicine, and the Department of Community Health Sciences, University of Calgary, Calgary; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada. The Alberta Biologics Pharmacosurveillance Program (ABioPharm) was supported by a grant from Alberta Health and Wellness for the study period reported. Data analyst costs were paid through the Department of Medicine and the Arthur J.E. Child Chair in Rheumatology, University of Calgary. C. Barnabe, MD, MSc, FRPC, Assistant Professor, Department of Medicine, and the Department of Community Health Sciences, University of Calgary; J. Homik, MD, MSc, FRCPC, Associate Professor, Department of Medicine, University of Alberta; S.G. Barr, MD, MSC, FRCPC, Associate Professor; L. Martin, MB, ChB, FRCPC, Professor, Department of Medicine, University of Calgary; W.P. Maksymowych, MB, ChB, FRCPC, Professor, Department of Medicine, University of Alberta. Address correspondence to Dr. C. Barnabe, 3330 Hospital Dr NW, Calgary, Alberta T2N 4N1, Canada. E-mail: ccbarnab@ucalgary.ca. Accepted for publication April 3, 2014.
Walter P. Maksymowych
From the Department of Medicine, and the Department of Community Health Sciences, University of Calgary, Calgary; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada. The Alberta Biologics Pharmacosurveillance Program (ABioPharm) was supported by a grant from Alberta Health and Wellness for the study period reported. Data analyst costs were paid through the Department of Medicine and the Arthur J.E. Child Chair in Rheumatology, University of Calgary. C. Barnabe, MD, MSc, FRPC, Assistant Professor, Department of Medicine, and the Department of Community Health Sciences, University of Calgary; J. Homik, MD, MSc, FRCPC, Associate Professor, Department of Medicine, University of Alberta; S.G. Barr, MD, MSC, FRCPC, Associate Professor; L. Martin, MB, ChB, FRCPC, Professor, Department of Medicine, University of Calgary; W.P. Maksymowych, MB, ChB, FRCPC, Professor, Department of Medicine, University of Alberta. Address correspondence to Dr. C. Barnabe, 3330 Hospital Dr NW, Calgary, Alberta T2N 4N1, Canada. E-mail: ccbarnab@ucalgary.ca. Accepted for publication April 3, 2014.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
The Effect of Different Remission Definitions on Identification of Predictors of Both Point and Sustained Remission in Rheumatoid Arthritis Treated with Anti-TNF Therapy
Cheryl Barnabe, Joanne Homik, Susan G. Barr, Liam Martin, Walter P. Maksymowych
The Journal of Rheumatology Jul 2014, jrheum.131451; DOI: 10.3899/jrheum.131451
The Effect of Different Remission Definitions on Identification of Predictors of Both Point and Sustained Remission in Rheumatoid Arthritis Treated with Anti-TNF Therapy
Cheryl Barnabe, Joanne Homik, Susan G. Barr, Liam Martin, Walter P. Maksymowych
The Journal of Rheumatology Jul 2014, jrheum.131451; DOI: 10.3899/jrheum.131451